These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 20275719
21. [Antibiotics in pulmonary tuberculosis; limits of effectiveness; the problem of bacilli remaining sensitive after chemotherapy]. COURTOIS R. Brux Med; 1955 Jul 31; 35(31):1531-52. PubMed ID: 13250270 [No Abstract] [Full Text] [Related]
22. Inhibition of growth of Mycobacterium tuberculosis by a mold product; the effect on pathogenic human tubercle bacilli. GERBER IE, GROSS M. Science; 1946 Feb 08; 103(2667):167-9. PubMed ID: 21012224 [No Abstract] [Full Text] [Related]
23. A serial investigation on the effect of tubercle endotoxoid in pulmonary tuberculosis. SALINGER PL. S Afr Med J; 1946 Jul 13; 20():375-84. PubMed ID: 20993965 [No Abstract] [Full Text] [Related]
24. Cycloheximide (antibiotic acti-dione) as a fungicide in solid media for growing tubercle bacilli from sputum. CORPER HJ, COHN ML. Antibiot Chemother (Northfield); 1952 Jan 13; 2(1):12-5. PubMed ID: 24541730 [No Abstract] [Full Text] [Related]
25. Plate Methods for Testing Antibiotic Activity of Actinomycetes against Virulent Human Type Tubercle Bacilli. Williston EH, Zia-Walrath P, Youmans GP. J Bacteriol; 1947 Nov 13; 54(5):563-8. PubMed ID: 16561393 [No Abstract] [Full Text] [Related]
27. [A study on the examination of resistant tubercle bacilli to kanamycin. 4th Report: Experiment with the modified III Kirchner agar media containing whole blood in place of serum]. OGAWA T, SAWAI T, SHIMADA H. Kekkaku; 1959 Nov 13; 34():797-800. PubMed ID: 14428396 [No Abstract] [Full Text] [Related]
29. [Medicosocial consequences of the resistance of the Koch bacillus to antibiotics]. MOLINA C, CONQUY T, ASSARAF W, PARENTI J. Alger Medicale; 1960 Mar 13; 64():278-80. PubMed ID: 14423352 [No Abstract] [Full Text] [Related]
33. [B C G and the new anti-tuberculosis drugs]. GLIKSMAN. Rev Med Moyen Orient; 1960 Mar 13; 4(5):209-13. PubMed ID: 20986318 [No Abstract] [Full Text] [Related]
34. A means of increasing the tuberculostatic effect of known chemotherapeutic agents. EISEMAN B. J Exp Med; 1948 Aug 13; 88(2):189-203. PubMed ID: 18873868 [Abstract] [Full Text] [Related]
35. Action of supernatants from combined growth of Fusarium solani and Pseudomonas aeruginosa against the tubercle bacillus. CARR LG. U S Nav Med Bull; 1946 Feb 13; 46():237. PubMed ID: 21026122 [No Abstract] [Full Text] [Related]
36. The occurrence of antibacterial substances active against Mycobacterium tuberculosis in seed plants. GOTTSHALL RY, LUCAS EH. J Clin Invest; 1949 Sep 13; 28(5 Pt 1):920-3. PubMed ID: 18138323 [No Abstract] [Full Text] [Related]
39. [The importance of determining the type of tubercle bacillus and antibiotics]. GERUDEN L, DEVOS A, GRAULICH R. Acta Tuberc Belg; 1954 Oct 13; 45(5):504-10. PubMed ID: 13217904 [No Abstract] [Full Text] [Related]
40. [Changes in the drug resistance of tubercle bacilli before and after chemotherapy of pulmonary tuberculosis]. OKUBO H. Kekkaku; 1961 Nov 13; 36():712-9. PubMed ID: 14481598 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]